Mumbai, Oct 6
The Maharashtra Food and Drugs Administration (FDA) has ordered an immediate halt to the sale, distribution, and use of Coldrif Syrup across the state, citing toxic adulteration linked to the tragic deaths of children in Madhya Pradesh and Rajasthan.
State Drug Controller DR Gahane issued a statement late Sunday night, alerting all licensees and the public to immediately freeze any stock of Coldrif Syrup (Phenylephrine Hydrochloride, Chlorpheniramine Maleate Syrup), Batch No SR-13, manufactured by Sresan Pharma, Kancheepuram District, Tamil Nadu. The specific batch, with manufacturing date May 2025 and expiry date April 2027, is allegedly contaminated with Diethylene Glycol (DEG), a poisonous substance, the statement said.
“In view of this, all the licensees and public are hereby instructed to immediately stop sale/distribution/use of Coldrif Syrup, Batch No. SR-13, if anybody is in possession, and report it to the local Drugs Control Authorities without delay,” Gahane said.